Antiretroviral Treatment Helps Reduce TB in HIV Patients in South Africa: Study

This article was reported by SABC (Johannesburg).

An article in SABC said a University of Cape Town (UCT) study conducted on adults enrolled in a public sector treatment program in the Free State, South Africa, found that antiretroviral (ARV) treatments assisted in reducing incidents of TB in HIV-positive individuals as well as the mortality of those infected with both diseases. According to UCT Researcher Vanessa Timmerman, "ARV is so highly effective in reducing the incidence of TB in these patients and also reducing mortality in this group of patients." However, approximately 13 million HIV-positive Africans do not have access to the required medications. Earlier this month, the World AIDS Campaign told an African AIDS conference that individuals in West and Central Africa are the worst affected by HIV/AIDS, but only a third have access to treatment.


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.